BRISBANE, 6 May 2026: ARM Hub welcomed AusBiotech for its Queensland BioBriefing at its Northgate facility last week, bringing together medtech manufacturers, investors, and industry leaders to examine what it will take to build sovereign manufacturing capability in Australia.

"Australia is facing a critical moment," said ARM Hub Chief Commercial Officer Samuel Jesuadian.

"Federal policy is shifting decisively towards urban manufacturing, and Queensland is at the right stage to prove that these capabilities already exist here."

ARM Hub CEO Professor Cori Stewart opened the evening with a clear statement of purpose.

"We really want to take great ideas and R&D and pull them through that commercial pathway and make sure they're commercially competitive. That's why ARM Hub exists."

The panel featured Gareth Keen from Cook Medical, Lauchlan Smart from The Endgame, and Lisa Cavallaro from the Brisbane Economic Development Agency, hosted by Jesuadian.

The panel zeroed in on closing the commercialisation gap, with Cavallaro direct about the stakes: "We are unapologetically supporting companies, a lot of which are medical device companies, to find that capital globally to ensure that innovation doesn't die on the vine."

On AI, Stewart cut through the noise. "It shouldn't be your board saying, 'What's your AI strategy?' It should be: “ What’s the business challenge you need to solve using AI?"

The reframe matters in a sector where Queensland's AI adoption still lags New South Wales and Victoria. Stewart noted that ARM Hub's Data and AI-as-a-Service model addresses this directly: manufacturers access AI capability without hiring a technical team, removing one of the most common barriers to adoption.

Cavallaro pointed to Brisbane's position as a hybrid market indicator of high yield and strong growth, with $18 billion in healthcare infrastructure investment anticipated ahead of the 2032 Olympics.

"With our pedigree of the R&D tax incentive and our regulatory frameworks, Australia is well-positioned. We're sixth globally for phase one and two clinical trials, and that puts us on the map," she said.

The evening closed with Hayley van der Meer, Director of Membership Services and Strategic Partnerships at AusBiotech, drawing the thread together.

"Breakthroughs in our sector don't happen in isolation. They certainly come from very strong connections. No single organisation can clearly take a product from the lab bench to bedside alone."

The BioBriefing is part of AusBiotech's national quarterly series. ARM Hub is one of four government-backed AI Adopt Centres operating across Australia, focused on helping SMEs adopt robotics, AI, and advanced manufacturing technologies.